A Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in Brazil

NCT06715254 · clinicaltrials.gov ↗
TERMINATED
Status
152
Enrollment
INDUSTRY
Sponsor class

Stopped Due to the limited availability of eligible patients who met the study's criteria, as well as there has not been a case of tuberculosis, the study was terminated early.

Conditions

Sponsor

Novartis Pharmaceuticals